RLMD Jan 2025 12.500 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

0.8000

0.0000

(0.00%)

As of 01:45PM EDT. Market open.

Loading interactive chart...

Insider Monkey
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q1 2024 Earnings Call Transcript
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q1 2024 Earnings Call Transcript May 10, 2024 Relmada Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). LifeSci Advisors: Sergio Traversa – Chief Executive Officer Maged Shenouda – Chief Financial Officer Andrew Cutler – Senior […]
Thomson Reuters StreetEvents
Q1 2024 Relmada Therapeutics Inc Earnings Call
Q1 2024 Relmada Therapeutics Inc Earnings Call
GuruFocus.com
Relmada Therapeutics Inc (RLMD) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Explore key financial outcomes and strategic updates from Relmada Therapeutics' first quarter of 2024, emphasizing advancements in clinical trials and operational efficiencies.